Matches in SemOpenAlex for { <https://semopenalex.org/work/W3172501391> ?p ?o ?g. }
- W3172501391 endingPage "2481" @default.
- W3172501391 startingPage "2469" @default.
- W3172501391 abstract "Eukaryotic initiation factor 4A (eIF4A), the enzymatic core of the eIF4F complex essential for translation initiation, plays a key role in the oncogenic reprogramming of protein synthesis, and thus is a putative therapeutic target in cancer. As important component of its anticancer activity, inhibition of translation initiation can alleviate oncogenic activation of HSF1, a stress-inducible transcription factor that enables cancer cell growth and survival. Here, we show that primary acute myeloid leukemia (AML) cells exhibit the highest transcript levels of eIF4A1 compared to other cancer types. eIF4A inhibition by the potent and specific compound rohinitib (RHT) inactivated HSF1 in these cells, and exerted pronounced in vitro and in vivo anti-leukemia effects against progenitor and leukemia-initiating cells, especially those with FLT3-internal tandem duplication (ITD). In addition to its own anti-leukemic activity, genetic knockdown of HSF1 also sensitized FLT3-mutant AML cells to clinical FLT3 inhibitors, and this synergy was conserved in FLT3 double-mutant cells carrying both ITD and tyrosine kinase domain mutations. Consistently, the combination of RHT and FLT3 inhibitors was highly synergistic in primary FLT3-mutated AML cells. Our results provide a novel therapeutic rationale for co-targeting eIF4A and FLT3 to address the clinical challenge of treating FLT3-mutant AML." @default.
- W3172501391 created "2021-06-22" @default.
- W3172501391 creator A5001035782 @default.
- W3172501391 creator A5001122693 @default.
- W3172501391 creator A5003260777 @default.
- W3172501391 creator A5004981982 @default.
- W3172501391 creator A5009423275 @default.
- W3172501391 creator A5016148729 @default.
- W3172501391 creator A5019700045 @default.
- W3172501391 creator A5020448123 @default.
- W3172501391 creator A5026435474 @default.
- W3172501391 creator A5040075148 @default.
- W3172501391 creator A5040490999 @default.
- W3172501391 creator A5045716415 @default.
- W3172501391 creator A5049134775 @default.
- W3172501391 creator A5062622724 @default.
- W3172501391 creator A5071005771 @default.
- W3172501391 creator A5078822934 @default.
- W3172501391 creator A5079262854 @default.
- W3172501391 creator A5080595793 @default.
- W3172501391 date "2021-06-14" @default.
- W3172501391 modified "2023-10-13" @default.
- W3172501391 title "Inhibition of translation initiation factor eIF4a inactivates heat shock factor 1 (HSF1) and exerts anti-leukemia activity in AML" @default.
- W3172501391 cites W1255676896 @default.
- W3172501391 cites W1454765678 @default.
- W3172501391 cites W1567091232 @default.
- W3172501391 cites W1965163574 @default.
- W3172501391 cites W1968852924 @default.
- W3172501391 cites W1981089896 @default.
- W3172501391 cites W1984209370 @default.
- W3172501391 cites W1997412169 @default.
- W3172501391 cites W1997806157 @default.
- W3172501391 cites W1999776725 @default.
- W3172501391 cites W2000732698 @default.
- W3172501391 cites W2000824929 @default.
- W3172501391 cites W2005056727 @default.
- W3172501391 cites W2011853681 @default.
- W3172501391 cites W2016054701 @default.
- W3172501391 cites W2018306702 @default.
- W3172501391 cites W2031134972 @default.
- W3172501391 cites W2049776490 @default.
- W3172501391 cites W2058258119 @default.
- W3172501391 cites W2065825082 @default.
- W3172501391 cites W2073160828 @default.
- W3172501391 cites W2096184369 @default.
- W3172501391 cites W2111291883 @default.
- W3172501391 cites W2112425781 @default.
- W3172501391 cites W2112519486 @default.
- W3172501391 cites W2113230030 @default.
- W3172501391 cites W2121565438 @default.
- W3172501391 cites W2125735390 @default.
- W3172501391 cites W2136159122 @default.
- W3172501391 cites W2136680138 @default.
- W3172501391 cites W2137476312 @default.
- W3172501391 cites W2145978712 @default.
- W3172501391 cites W2152214606 @default.
- W3172501391 cites W2153475997 @default.
- W3172501391 cites W2157230060 @default.
- W3172501391 cites W2157504723 @default.
- W3172501391 cites W2161011316 @default.
- W3172501391 cites W2168805216 @default.
- W3172501391 cites W2278250712 @default.
- W3172501391 cites W2289433143 @default.
- W3172501391 cites W2342976696 @default.
- W3172501391 cites W2400990766 @default.
- W3172501391 cites W2419140434 @default.
- W3172501391 cites W2471550966 @default.
- W3172501391 cites W2474079873 @default.
- W3172501391 cites W2559537906 @default.
- W3172501391 cites W2560012305 @default.
- W3172501391 cites W2612719504 @default.
- W3172501391 cites W2715749014 @default.
- W3172501391 cites W2804431359 @default.
- W3172501391 cites W2896480326 @default.
- W3172501391 cites W2906690049 @default.
- W3172501391 cites W2945196694 @default.
- W3172501391 cites W2948785198 @default.
- W3172501391 cites W2954467291 @default.
- W3172501391 cites W2973112770 @default.
- W3172501391 cites W2982353618 @default.
- W3172501391 cites W2988312256 @default.
- W3172501391 cites W2989893822 @default.
- W3172501391 cites W2992516532 @default.
- W3172501391 cites W3000736974 @default.
- W3172501391 cites W3003171204 @default.
- W3172501391 cites W3048827006 @default.
- W3172501391 doi "https://doi.org/10.1038/s41375-021-01308-z" @default.
- W3172501391 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34127794" @default.
- W3172501391 hasPublicationYear "2021" @default.
- W3172501391 type Work @default.
- W3172501391 sameAs 3172501391 @default.
- W3172501391 citedByCount "12" @default.
- W3172501391 countsByYear W31725013912022 @default.
- W3172501391 countsByYear W31725013912023 @default.
- W3172501391 crossrefType "journal-article" @default.
- W3172501391 hasAuthorship W3172501391A5001035782 @default.
- W3172501391 hasAuthorship W3172501391A5001122693 @default.
- W3172501391 hasAuthorship W3172501391A5003260777 @default.